TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
NRXP

NRX Pharmaceuticals Inc

Healthcare · Biotechnology

3.30$ -2.1% vs. previous close Closing price · As of: Sep 18, 2026

Investor relations

Report Dates

Investor relations overview for NRX Pharmaceuticals Inc (NRXP): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 08/17/2026.

Next report 08/17/2026
Last report 08/14/2026
Earnings surprise by quarter (%)
Q3 23 · 39.1 % 23 Q4 23 · 37.5 % 23 Q1 24 · -34.6 % 24 Q2 24 · -8.7 % 24 Q3 24 · 77.3 % 24 Q4 24 · -108.1 % 24 Q1 25 · 35.9 % 25 Q2 25 · -326.1 % 25 Q3 25 · -2,450.0 % 25 Q4 25 · 329.1 % 25 Q1 26 · 63.6 % 26 Q2 26 · -100.0 % 26

EPS estimate beaten

Full history 7 of 18 quarters (39%)
Last 16 quarters 7 of 16 quarters (44%)

Earnings Call Transcripts

Search all transcripts →

No transcripts yet — they will show up here automatically after the next earnings call.

News on This Stock

  • 09/16/2026 NRX Pharmaceuticals, Inc. (NRXP): Other Events; Financial Statements and Exhibits · sec.gov Open ↗
  • 09/14/2026 NRX Pharmaceuticals, Inc. (NRXP): Regulation FD Disclosure; Financial Statements and Exhibits · sec.gov Open ↗
  • 08/17/2026 NRX Pharmaceuticals, Inc. (NRXP): Results of Operations and Financial Condition; Financial Statements and Exhibits · sec.gov Open ↗
  • 08/07/2026 NRX Pharmaceuticals, Inc. (NRXP): Regulation FD Disclosure · sec.gov Open ↗
  • 07/22/2026 NRX Pharmaceuticals, Inc. (NRXP): Other Events · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?